PBPH vs. XLVI
PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) and XLVI (State Street Health Care Select Sector SPDR Premium Income ETF) are both exchange-traded funds - PBPH is a Health & Biotech Equities fund tracking the BITA Global Pharma and Biotech Select Index, while XLVI is a Derivative Income fund actively managed by State Street. PBPH is passively managed, while XLVI is actively managed. Their correlation of 0.86 suggests significant overlap in exposure. PBPH charges 0.13%/yr vs 0.35%/yr for XLVI.
Performance
PBPH vs. XLVI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PBPH achieves a -1.13% return, which is significantly lower than XLVI's -0.67% return.
PBPH
- 1D
- 0.58%
- 1M
- 0.07%
- YTD
- -1.13%
- 6M
- -0.02%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XLVI
- 1D
- 0.67%
- 1M
- 2.30%
- YTD
- -0.67%
- 6M
- 0.76%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PBPH vs. XLVI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | -1.13% | 0.76% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | -0.67% | 0.81% |
Correlation
The correlation between PBPH and XLVI is 0.86, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 26, 2025 | 0.86 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PBPH vs. XLVI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| PBPH | XLVI | Difference | |
|---|---|---|---|
Sharpe Ratio (All Time)Calculated using the full available price history | -0.04 | 1.33 | -1.37 |
Drawdowns
PBPH vs. XLVI - Drawdown Comparison
The maximum PBPH drawdown since its inception was -11.10%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for PBPH and XLVI.
Loading charts...
Drawdown Indicators
| PBPH | XLVI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -11.10% | -8.14% | -2.96% |
Current DrawdownCurrent decline from peak | -8.69% | -4.02% | -4.67% |
Average DrawdownAverage peak-to-trough decline | -4.23% | -1.95% | -2.28% |
Volatility
PBPH vs. XLVI - Volatility Comparison
Loading charts...
Volatility by Period
| PBPH | XLVI | Difference | |
|---|---|---|---|
Volatility (1Y)Calculated over the trailing 1-year period | 16.78% | 10.94% | +5.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.78% | 10.94% | +5.84% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.78% | 10.94% | +5.84% |
PBPH vs. XLVI - Expense Ratio Comparison
PBPH has a 0.13% expense ratio, which is lower than XLVI's 0.35% expense ratio.
Dividends
PBPH vs. XLVI - Dividend Comparison
PBPH's dividend yield for the trailing twelve months is around 0.09%, less than XLVI's 11.53% yield.
| Position | TTM | 2025 |
|---|---|---|
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | 11.53% | 5.73% |
Frequently Asked Questions
PBPH and XLVI have a correlation of 0.86, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PBPH is cheaper with a 0.13% expense ratio, compared with 0.35% for XLVI.
XLVI has the higher dividend yield at 11.53%, compared with 0.09% for PBPH.
PBPH is categorized as Health & Biotech Equities, while XLVI is Derivative Income. They also come from different issuers: Portfolio Building Block and State Street. Their fees differ too: 0.13% for PBPH and 0.35% for XLVI.
Find the right allocation for PBPH and XLVI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer